Why the study?
Can quetiapine induce fatal neuroleptic malignant syndrome in an elderly patient with Parkinson disease?
Can quetiapine induce fatal neuroleptic malignant syndrome in an elderly patient with Parkinson disease?
Quetiapine can rarely cause severe, abrupt-onset, and fatal neuroleptic malignant syndrome, necessitating prompt recognition and drug withdrawal.
Answers are grounded in this paper and cite their sources.
Quetiapine may trigger fatal NMS in Parkinson disease; leaves open safer antipsychotic options for this population.
Acute psychosis developed in an elderly patient with Parkinson disease and she was admitted and treated with quetiapine (Seroquel). One day later, high fever unexplained by infection appeared associated with restlessness, confusion, convulsion, leukocytosis, and extreme serum creatine kinase levels. She died of neuroleptic malignant syndrome (NMS) despite intensive treatment. Quetiapine is an atypical neuroleptic agent, rarely associated with NMS in the absence of other contributing drugs. Our case strongly establishes quetiapine-induced NMS (Naranjo scale 6) and is also unique in the abrupt onset and severe refractory course. The steep increase in the prescription of quetiapine worldwide mandates better recognition of this severe adverse reaction, which is fortunately rare, to allow immediate drug withdrawal and appropriate treatment.
No takes yet. Share an insight, caveat, or question.
Schattner et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: